From the Research
Magnesium supplementation may be beneficial for some patients with Post-Acute COVID-19 Syndrome, particularly those experiencing fatigue, muscle weakness, or heart palpitations, with a recommended dose of 200-400mg daily of magnesium glycinate or magnesium citrate. The most recent and highest quality study, 1, suggests that combined magnesium and vitamin D deficiencies may associate with a higher number of clinical manifestations in long COVID patients, highlighting the potential synergistic effects of these deficiencies. However, it is essential to note that the current evidence is not yet conclusive, and more research is needed to determine the effectiveness of magnesium supplementation in managing long COVID symptoms.
When considering magnesium supplementation, it is crucial to start with a lower dose and gradually increase to avoid digestive side effects. Taking the supplement with food and dividing the dose throughout the day can enhance absorption. Magnesium plays vital roles in energy production, muscle function, and nervous system regulation, which may be particularly beneficial for long COVID patients who have reported fatigue and muscle weakness. Nevertheless, before initiating any supplement, it is essential to consult with a healthcare provider, especially for individuals with kidney disease or those taking medications that may interact with magnesium.
A comprehensive approach to managing long COVID symptoms should include proper rest, gradual return to activity, and addressing other nutritional needs. While magnesium supplementation may help alleviate some symptoms, it should not be relied upon as the sole treatment. The lack of standard tests and drug treatments for long COVID, as highlighted in 2 and 3, emphasizes the need for a holistic treatment strategy that incorporates established treatment paradigms and supportive care. Ultimately, the management of long COVID requires continuous careful observation and further studies to determine the long-term impact of COVID-19 and develop effective treatment pathways.